Biovista partners with biopharma and biotech companies, public and private organizations and academic institutes. Click on the links to find out more about some of these collaborations.
Biovista is collaborating with the FDA on predicting adverse events of drug classes. …more
Biovista is collaborating with Hewlett Packard Enterprise on next generation AI and Big Data Analytics to advance real-world personalized medicine at community hospital settings.…more
Sarah Bush Lincoln to Use Biovista’s Project Prodigy Artificial Intelligence Engine to Identify and Validate New Therapeutic Options for Further Research. …more
Biovista Inc. Announces Drug Repositioning Collaboration with Astellas Pharma. …more
We have partnered with Pfizer to reposition a number of their drugs. …more
Biovista helped Novartis reposition drugs in collaboration with the New Indications Discovery Unit. …more
Dart Therapeutics uses Biovista’s drug repositioning capability to develop promising therapies for Duchenne Muscular Dystrophy. …more
We worked with Cempra to clarify the risk profile of one of the company’s early compounds. …more
Biovista Sponsors Wylder Nation Foundation’s Research on Acid Sphingomyelinase Deficiency. …more
Biovista is collaborating with the CFIDS Association of America to help understand and find a cure for Chronic Fatigue Syndrome. …more
The Thalassaemia International Federation is using Biovista’s EHR JAnaemia platform to collect and analyze Electronic Health Records. …more
Biotrend Chemikalien GmbH awards contract to Biovista Inc. for its Vizit literature search tool. …more
Novus Biologicals awards contract to Biovista Inc. to drive its web-based Novus Explorer service. …more
StressMarq licenses Biovista Vizit to drive its website customer experience.